Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study
Abstract
We aimed to estimate the frequency of each AT(N) (β‐amyloid deposition [A], pathologic tau [T], and neurodegeneration [N]) profile in different clinical diagnosis groups and to describe the longitudinal change in clinical outcomes of individuals in each group.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Aug 06, 2019
- Source ID
- 10.1016/j.jalz.2019.05.006
Entities
People
- An Pan
- Bo Song
- Chen‐chen Tan
- De‐hu Li
- Hui‐fu Wang
- Jie‐qiong Li
- Jin‐tai Yu
- John Suckling
- Lan Tan
- Lin Feng
- Michael M. Weiner
- Paul S. Aisen
- Qiang Dong
- Shan‐liang Zhu
- The Alzheimer’s Disease Neuroimaging Initiative*
- Vincent Mok
- Yan‐jiang Wang
Organizations
- Army Medical University
- Canadian Institutes of Health Research
- Fudan University
- Loma Linda University Medical Center
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- National Natural Science Foundation of China
- Northern California Institute for Research and Education
- Qingdao University
- Qingdao University of Science and Technology
- Shanghai Municipal Science and Technology Commission
- The Chinese University of Hong Kong
- Tongji Medical College
- United States Department of Defense
- University of California
- University of California, San Francisco
- University of Cambridge
- University of Southern California